Inspire Advisors’s AngioDynamics ANGO Stock Holding History

Inspire Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,779	Closed	-$27K	–	117
2020 Q4	$27K	Buy	+1,779	New	+$22.6K	0.01%	318

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Inspire Advisors's ANGO Position: Q1 2021 in Review

Inspire Advisors sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 1,779 shares — an estimated $27K sold.

Inspire Advisors first reported a position in ANGO in Q4 2020 and held it in 1 quarter. The position peaked at $27K in Q4 2020. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

Inspire Advisors reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 1,779 AngioDynamics shares in Q1 2021, an estimated $27K.
Inspire Advisors first reported a position in AngioDynamics in Q4 2020 and held it in 1 quarter.
Inspire Advisors's AngioDynamics position peaked at $27K in Q4 2020.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.